1RHF - JenaLib

Asymmetric Unit (Jmol Viewer)

Asym. Unit - sites (Jmol Viewer)

Biological Unit 1 (Jmol Viewer)

Biol. Unit 1 - sites (Jmol Viewer)

Biological Unit 2 (Jmol Viewer)

Title :   CRYSTAL STRUCTURE OF HUMAN TYRO3-D1D2

Authors :   C. Heiring, B. Dahlback, Y. A. Muller

Date :   14 Nov 03 (Deposition) - 23 Mar 04 (Release) - 13 Jul 11 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   1.96

Chains :   Asym. Unit : A,B
Biol. Unit 1: A  (1x)
Biol. Unit 2: B  (1x)

Keywords :   Axl/Tyro3 Family, Cellular Adhesion, Ligand-Independent Dimerization, Mutational Analysis, Transferase (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   C. Heiring, B. Dahlback, Y. A. Muller
Ligand Recognition And Homophilic Interactions In Tyro3: Structural Insights Into The Axl/Tyro3 Receptor Tyrosine Kinase Family.
J. Biol. Chem. V. 279 6952 2004
PubMed-ID: 14623883 | Reference-DOI: 10.1074/JBC.M311750200

Molecule 1 - TYROSINE-PROTEIN KINASE RECEPTOR TYRO3
	Chains	:	A, B
	EC Number	:	2.7.1.112
	Engineered	:	YES
	Expression System	:	ESCHERICHIA COLI
	Expression System Plasmid	:	PET21A+
	Expression System Taxid	:	562
	Expression System Vector Type	:	PLASMID
	Fragment	:	N-TERMINAL IG-DOMAIN
	Gene	:	TYRO3, RSE, SKY, DTK, BYK
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	TYROSINE-PROTEIN KINASE RSE, TYROSINE-PROTEIN KINASE SKY, TYROSINE-PROTEIN KINASE DTK, PROTEIN-TYROSINE KINASE BYK

		1	2
Asymmetric Unit	:	A	B
Biological Unit 1 (1x)	:	A
Biological Unit 2 (1x)	:		B

Summary Information (see also Sequences/Alignments below)

Asymmetric Unit (4, 10)

No.	Name	Count	Type	Full Name
1	ACT	4	Ligand/Ion	ACETATE ION
2	EPE	1	Ligand/Ion	4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID
3	MSE	4	Mod. Amino Acid	SELENOMETHIONINE
4	ZN	1	Ligand/Ion	ZINC ION

Biological Unit 1 (2, 5)

No.	Name	Count	Type	Full Name
1	ACT	3	Ligand/Ion	ACETATE ION
2	EPE	-1	Ligand/Ion	4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID
3	MSE	2	Mod. Amino Acid	SELENOMETHIONINE
4	ZN	-1	Ligand/Ion	ZINC ION

Biological Unit 2 (3, 4)

No.	Name	Count	Type	Full Name
1	ACT	1	Ligand/Ion	ACETATE ION
2	EPE	1	Ligand/Ion	4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID
3	MSE	2	Mod. Amino Acid	SELENOMETHIONINE
4	ZN	-1	Ligand/Ion	ZINC ION

Asymmetric Unit (6, 6)

No.	Name	Evidence	Residues	Description
1	AC1	SOFTWARE	HIS A:166 , ACT A:302 , HOH A:423 , HIS B:166	BINDING SITE FOR RESIDUE ZN A 301
2	AC2	SOFTWARE	HIS A:166 , ASN A:167 , LEU A:168 , ZN A:301 , HOH A:363 , HIS B:166	BINDING SITE FOR RESIDUE ACT A 302
3	AC3	SOFTWARE	ARG A:74 , THR A:176	BINDING SITE FOR RESIDUE ACT A 303
4	AC4	SOFTWARE	ARG B:74 , TRP B:76 , THR B:176 , EPE B:306 , HOH B:342	BINDING SITE FOR RESIDUE ACT B 304
5	AC5	SOFTWARE	ASP A:107 , LEU A:108 , HIS A:180 , ASP B:107 , LEU B:108 , ALA B:109 , HIS B:180 , HOH B:419	BINDING SITE FOR RESIDUE ACT A 305
6	AC6	SOFTWARE	TRP B:76 , ILE B:87 , SER B:88 , ACT B:304 , HOH B:388	BINDING SITE FOR RESIDUE EPE B 306

Asymmetric Unit

No.	Residues
1	A:24	-	A:77
2	A:120	-	A:163
3	B:24	-	B:77
4	B:120	-	B:163

Asymmetric Unit

No.	Residues
1	Gly A:124	-	Pro A:125
2	Pro A:125	-	Pro A:126
3	Glu A:127	-	Pro A:128
4	Gly A:142	-	Pro A:143
5	Ser A:146	-	Pro A:147
6	Gly B:124	-	Pro B:125
7	Pro B:125	-	Pro B:126
8	Glu B:127	-	Pro B:128
9	Gly B:142	-	Pro B:143
10	Ser B:146	-	Pro B:147

(no "SAP(SNP)/Variant" information available for 1RHF)

(no "PROSITE Motif" information available for 1RHF)

Asymmetric Unit (4, 8)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1	ENST00000263798	1	ENSE00001152512	chr15:41851232-41851579	348	TYRO3_HUMAN	1-42	42	0	-	-
1.2	ENST00000263798	2	ENSE00001106734	chr15:41853325-41853508	184	TYRO3_HUMAN	42-103	62	2	A:7-63 B:7-63	57 57
1.3	ENST00000263798	3	ENSE00000586489	chr15:41853737-41853837	101	TYRO3_HUMAN	103-137	35	2	A:63-97 B:63-97	35 35
1.4	ENST00000263798	4	ENSE00000676763	chr15:41854746-41854916	171	TYRO3_HUMAN	137-194	58	2	A:97-154 B:97-154	58 58
1.5	ENST00000263798	5	ENSE00000586496	chr15:41856382-41856468	87	TYRO3_HUMAN	194-223	30	2	A:154-182 B:154-182	29 29
1.6	ENST00000263798	6	ENSE00000676767	chr15:41857224-41857339	116	TYRO3_HUMAN	223-261	39	0	-	-
1.7	ENST00000263798	7	ENSE00000586427	chr15:41859558-41859735	178	TYRO3_HUMAN	262-321	60	0	-	-
1.8	ENST00000263798	8	ENSE00000676806	chr15:41860415-41860560	146	TYRO3_HUMAN	321-369	49	0	-	-
1.9	ENST00000263798	9	ENSE00000586436	chr15:41861076-41861220	145	TYRO3_HUMAN	370-418	49	0	-	-
1.10	ENST00000263798	10	ENSE00000676821	chr15:41862225-41862354	130	TYRO3_HUMAN	418-461	44	0	-	-
1.11	ENST00000263798	11	ENSE00000586447	chr15:41862438-41862538	101	TYRO3_HUMAN	461-495	35	0	-	-
1.12	ENST00000263798	12	ENSE00000586453	chr15:41862802-41862897	96	TYRO3_HUMAN	495-527	33	0	-	-
1.13	ENST00000263798	13	ENSE00000676824	chr15:41863236-41863316	81	TYRO3_HUMAN	527-554	28	0	-	-
1.14	ENST00000263798	14	ENSE00000586464	chr15:41863793-41863885	93	TYRO3_HUMAN	554-585	32	0	-	-
1.15	ENST00000263798	15	ENSE00000676826	chr15:41864641-41864762	122	TYRO3_HUMAN	585-625	41	0	-	-
1.16	ENST00000263798	16	ENSE00000586471	chr15:41865200-41865309	110	TYRO3_HUMAN	626-662	37	0	-	-
1.17	ENST00000263798	17	ENSE00000884066	chr15:41865506-41865665	160	TYRO3_HUMAN	662-715	54	0	-	-
1.18	ENST00000263798	18	ENSE00000676867	chr15:41865877-41866013	137	TYRO3_HUMAN	716-761	46	0	-	-
1.19	ENST00000263798	19	ENSE00001152503	chr15:41870084-41871536	1453	TYRO3_HUMAN	761-890	130	0	-	-

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:176
 aligned with TYRO3_HUMAN | Q06418 from UniProtKB/Swiss-Prot  Length:890

    Alignment length:176
                                    56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216      
          TYRO3_HUMAN    47 GAPVKLTVSQGQPVKLNCSVEGMEEPDIQWVKDGAVVQNLDQLYIPVSEQHWIGFLSLKSVERSDAGRYWCQVEDGGETEISQPVWLTVEGVPFFTVEPKDLAVPPNAPFQLSCEAVGPPEPVTIVWWRGTTKIGGPAPSPSVLNVTGVTQSTMFSCEAHNLKGLASSRTATVHLQ 222
               SCOP domains d1rhfa1 A:7-97 Tyrosine-protein kinase receptor tyro3, N-terminal domain                   d1rhfa2 A:98-182 Tyrosine-protein kinase receptor tyro3, second domain                SCOP domains
               CATH domains 1rhfA01 A:7-97 Immunoglobulins                                                             1rhfA02 A:98-182 Immunoglobulins                                                      CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ...eeeeee....eeeeeeee......eeeee..ee....eeeeeeee..eeeeeeee...hhhhheeeeeee......ee...eeeeee...eeee....eee.....eeeeeeee......eeeeee..ee....ee..eeeee......eeeeeeeee..eeee...eeeee. Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.2  PDB: A:7-63 UniProt: 42-103 [INCOMPLETE]       ---------------------------------Exon 1.4  PDB: A:97-154 UniProt: 137-194                  ---------------------------- Transcript 1 (1)
           Transcript 1 (2) --------------------------------------------------------Exon 1.3  PDB: A:63-97             --------------------------------------------------------Exon 1.5  PDB: A:154-182      Transcript 1 (2)
                 1rhf A   7 GAPVKLTVSQGQPVKLNCSVEGmEEPDIQWVKDGAVVQNLDQLYIPVSEQHWIGFLSLKSVERSDAGRYWCQVEDGGETEISQPVWLTVEGVPFFTVEPKDLAVPPNAPFQLSCEAVGPPEPVTIVWWRGTTKIGGPAPSPSVLNVTGVTQSTmFSCEAHNLKGLASSRTATVHLQ 182
                                    16        26  |     36        46        56        66        76        86        96       106       116       126       136       146       156   |   166       176      
                                                 29-MSE                                                                                                                            160-MSE

Chain B from PDB  Type:PROTEIN  Length:176
 aligned with TYRO3_HUMAN | Q06418 from UniProtKB/Swiss-Prot  Length:890

    Alignment length:176
                                    56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216      
          TYRO3_HUMAN    47 GAPVKLTVSQGQPVKLNCSVEGMEEPDIQWVKDGAVVQNLDQLYIPVSEQHWIGFLSLKSVERSDAGRYWCQVEDGGETEISQPVWLTVEGVPFFTVEPKDLAVPPNAPFQLSCEAVGPPEPVTIVWWRGTTKIGGPAPSPSVLNVTGVTQSTMFSCEAHNLKGLASSRTATVHLQ 222
               SCOP domains d1rhfb1 B:7-97 Tyrosine-protein kinase receptor tyro3, N-terminal domain                   d1rhfb2 B:98-182 Tyrosine-protein kinase receptor tyro3, second domain                SCOP domains
               CATH domains 1rhfB01 B:7-97 Immunoglobulins                                                             1rhfB02 B:98-182 Immunoglobulins                                                      CATH domains
           Pfam domains (1) I-set-1rhfB01 B:7-95                                                                     ------Ig_3-1rhfB03 B:102-167                                            --------------- Pfam domains (1)
           Pfam domains (2) I-set-1rhfB02 B:7-95                                                                     ------Ig_3-1rhfB04 B:102-167                                            --------------- Pfam domains (2)
         Sec.struct. author ...eeeeee....eeeeeeee......eeeee..ee.....eeeeeee..eeeeeeee...hhhhheeeeeee......ee...eeeeee...eeee....eee.....eeeeeeee......eeeeee..ee....ee..eeeee......eeeeeeeee..eeee...eeeee. Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.2  PDB: B:7-63 UniProt: 42-103 [INCOMPLETE]       ---------------------------------Exon 1.4  PDB: B:97-154 UniProt: 137-194                  ---------------------------- Transcript 1 (1)
           Transcript 1 (2) --------------------------------------------------------Exon 1.3  PDB: B:63-97             --------------------------------------------------------Exon 1.5  PDB: B:154-182      Transcript 1 (2)
                 1rhf B   7 GAPVKLTVSQGQPVKLNCSVEGmEEPDIQWVKDGAVVQNLDQLYIPVSEQHWIGFLSLKSVERSDAGRYWCQVEDGGETEISQPVWLTVEGVPFFTVEPKDLAVPPNAPFQLSCEAVGPPEPVTIVWWRGTTKIGGPAPSPSVLNVTGVTQSTmFSCEAHNLKGLASSRTATVHLQ 182
                                    16        26  |     36        46        56        66        76        86        96       106       116       126       136       146       156   |   166       176      
                                                 29-MSE                                                                                                                            160-MSE

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Asymmetric Unit

Classes(

)

Architectures( (-)

)

Topologies( (-)

)

Homologous Superfamilies( (-)

)

Organisms( (-)

)

Class: Mainly Beta (13760)

Architecture: Sandwich (5577)

Topology: Immunoglobulin-like (3897)

Homologous Superfamily: Immunoglobulins (2282)

Human (Homo sapiens) (912)

1a	1rhfA01	A:7-97
1b	1rhfB01	B:7-97
1c	1rhfA02	A:98-182
1d	1rhfB02	B:98-182

Asymmetric Unit

Clans(

)

Families(

)

Organisms( (-)

)

Clan: Ig (577)

Family: I-set (67)

Homo sapiens (Human) (50)

1a	I-set-1rhfB01	B:7-95
1b	I-set-1rhfB02	B:7-95

Family: Ig_3 (11)

Homo sapiens (Human) (9)

2a	Ig_3-1rhfB03	B:102-167
2b	Ig_3-1rhfB04	B:102-167

Asymmetric Unit(hide GO term definitions)

Chain A,B (TYRO3_HUMAN | Q06418)

molecular function
	GO:0005524	ATP binding	Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
	GO:0016301	kinase activity	Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
	GO:0000166	nucleotide binding	Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
	GO:0043548	phosphatidylinositol 3-kinase binding	Interacting selectively and non-covalently with a phosphatidylinositol 3-kinase, any enzyme that catalyzes the addition of a phosphate group to an inositol lipid at the 3' position of the inositol ring.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0046982	protein heterodimerization activity	Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
	GO:0004672	protein kinase activity	Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
	GO:0004713	protein tyrosine kinase activity	Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
	GO:0004716	signal transducer, downstream of receptor, with protein tyrosine kinase activity	Conveys a signal from an upstream receptor or intracellular signal transducer by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
	GO:0016740	transferase activity	Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
	GO:0004714	transmembrane receptor protein tyrosine kinase activity	Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
	GO:0001618	virus receptor activity	Combining with a virus component and mediating entry of the virus into the cell.
biological process
	GO:0043277	apoptotic cell clearance	The recognition and removal of an apoptotic cell by a neighboring cell or by a phagocyte.
	GO:0007155	cell adhesion	The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
	GO:0021885	forebrain cell migration	The orderly movement of a cell from one site to another at least one of which is located in the forebrain.
	GO:0001779	natural killer cell differentiation	The process in which a relatively unspecialized cell acquires the specialized features of a natural killer cell.
	GO:0050728	negative regulation of inflammatory response	Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
	GO:0045824	negative regulation of innate immune response	Any process that stops, prevents, or reduces the frequency, rate or extent of the innate immune response.
	GO:0051250	negative regulation of lymphocyte activation	Any process that stops, prevents, or reduces the frequency, rate or extent of lymphocyte activation.
	GO:0043524	negative regulation of neuron apoptotic process	Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
	GO:0034122	negative regulation of toll-like receptor signaling pathway	Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor signaling pathway.
	GO:0070050	neuron cellular homeostasis	The cellular homeostatic process that preserves a neuron in a stable, differentiated functional and structural state.
	GO:0042698	ovulation cycle	The type of sexual cycle seen in females, often with physiologic changes in the endometrium that recur at regular intervals during the reproductive years.
	GO:0018108	peptidyl-tyrosine phosphorylation	The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
	GO:0014065	phosphatidylinositol 3-kinase signaling	A series of reactions within the signal-receiving cell, mediated by the intracellular phosphatidylinositol 3-kinase (PI3K). Many cell surface receptor linked signaling pathways signal through PI3K to regulate numerous cellular functions.
	GO:0016310	phosphorylation	The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
	GO:0030168	platelet activation	A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
	GO:0070527	platelet aggregation	The adhesion of one platelet to one or more other platelets via adhesion molecules.
	GO:0046777	protein autophosphorylation	The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
	GO:0043491	protein kinase B signaling	A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
	GO:0006468	protein phosphorylation	The process of introducing a phosphate group on to a protein.
	GO:0032940	secretion by cell	The controlled release of a substance by a cell.
	GO:0007165	signal transduction	The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
	GO:0023014	signal transduction by protein phosphorylation	A process in which the transfer of one or more phosphate groups to a substrate transmits a signal to the phosphorylated substrate.
	GO:0007283	spermatogenesis	The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
	GO:0034446	substrate adhesion-dependent cell spreading	The morphogenetic process that results in flattening of a cell as a consequence of its adhesion to a substrate.
	GO:0060068	vagina development	The reproductive developmental process whose specific outcome is the progression of the vagina over time, from its formation to the mature structure.
	GO:0046718	viral entry into host cell	The process that occurs after viral attachment by which a virus, or viral nucleic acid, breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the viral nucleic acid is released into the host cell cytoplasm.
	GO:0016032	viral process	A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.
cellular component
	GO:0005789	endoplasmic reticulum membrane	The lipid bilayer surrounding the endoplasmic reticulum.
	GO:0016021	integral component of membrane	The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0005887	integral component of plasma membrane	The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005635	nuclear envelope	The double lipid bilayer enclosing the nucleus and separating its contents from the rest of the cytoplasm; includes the intermembrane space, a gap of width 20-40 nm (also called the perinuclear space).
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		ACT	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		EPE	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		MSE	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		ZN	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Glu A:127 - Pro A:128	[ RasMol ]
		Glu B:127 - Pro B:128	[ RasMol ]
		Gly A:124 - Pro A:125	[ RasMol ]
		Gly A:142 - Pro A:143	[ RasMol ]
		Gly B:124 - Pro B:125	[ RasMol ]
		Gly B:142 - Pro B:143	[ RasMol ]
		Pro A:125 - Pro A:126	[ RasMol ]
		Pro B:125 - Pro B:126	[ RasMol ]
		Ser A:146 - Pro A:147	[ RasMol ]
		Ser B:146 - Pro B:147	[ RasMol ]

Biological Units
	Complete Structure
		Biological Unit 1	[ Jena3D ]
		Biological Unit 2	[ Jena3D ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym. Unit PNG format \| Asym. Unit - sites PNG format \| Biol. Unit 1 PNG format \| Biol. Unit 1 - sites PNG format \| Biol. Unit 2 PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	1rhf
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	TYRO3_HUMAN \| Q06418
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	2.7.1.112
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	(no 'MIM ID' available)
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	TYRO3_HUMAN \| Q06418
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

(no "Entries Sharing at Least One Protein Chain" available for 1RHF)

(no "Related Entries Specified in the PDB File" available for 1RHF)

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (4, 10)

Sites (6, 6)

SS Bonds (4, 4)

Cis Peptide Bonds (10, 10)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (0, 0)

PROSITE Motifs (0, 0)

Exons (4, 8)

Sequences/Alignments

Classification and Annotation

SCOP Domains (2, 4)

CATH Domains (1, 4)

Pfam Domains (2, 4)

Gene Ontology (46, 46)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File